Blood transfusion strategies and ECMO during the COVID-19 pandemic
Lancet Respir Med
.
2020 May;8(5):e40.
doi: 10.1016/S2213-2600(20)30173-9.
Epub 2020 Apr 16.
Authors
David Koeckerling
1
,
Daniel Pan
2
,
N Lakmal Mudalige
3
,
Oluwatobiloba Oyefeso
4
,
Joseph Barker
5
Affiliations
1
Medical Sciences Division, University of Oxford, Oxford, UK.
2
Department of Respiratory Medicine, University of Leicester, Leicester LE1 7RH, UK.
3
London School of Tropical Medicine, London, UK.
4
Department of Primary Care, Royal Free London NHS Foundation Trust, London, UK.
5
Department of Cardiovascular Sciences, University of Leicester, Leicester LE1 7RH, UK. Electronic address: joseph.barker@nhs.net.
PMID:
32305078
PMCID:
PMC7162621
DOI:
10.1016/S2213-2600(20)30173-9
No abstract available
Publication types
Letter
Comment
MeSH terms
Betacoronavirus
Blood Transfusion
COVID-19
Communicable Diseases, Emerging*
Coronavirus Infections
Extracorporeal Membrane Oxygenation*
Humans
Pandemics
Pneumonia, Viral
Respiratory Distress Syndrome*
SARS-CoV-2